Lilly’s obesity pill, orforglipron, gets FDA fast-track voucher

Please subscribe to IBJ to decode this article.

ioth Uh ieelrcd rfyaL,llrie oiettsi a aooitoil g.tureiDhionyaFgfnsEov.dllt polte-alidpf aptcagsei-i t lye cAevrhra ry i ,git nCeiaumtiikmnflns nlpbdrrra o ogsogo.nsvdirt ura re .w gr s nwof asprS

inea undenaif hleo .yidnooag7rd,ttac0 srnoliMam n h%yo ur,rr$9etg oLa 5bw Sup

fockpnyoaeAD yrholrspmint rsheiirui,t emrsraai eA rmLntmoPent Veoei lwr goo i’Cprcariatr pnlwc sooex’mdosdeF e r, cedtceisieaie. ricita fggtcoee,totaauiirohLleen ltm pteeNiviuaaltentdhD v ct epsg oFso rdslrna ann

ldrrnnsuomghoobs r ouler p b 6armaalpartyiyfioT e flis a vrne2so tpfbt tmiofy iorilsl a booenm. hrt taoltoareotryegtvarueteftid o tgtiy oo d ysrentbeia apt0h c e n le n liete yausood2rteseo hsf etihgtoify .t lLraTa apetnnilbays roprsehirt2opifoomrp uulptgl

icd n i.au ppousou m,dremenbh easpy”s atcfvl a Dhucdstsart dtraraatid dedn iMa n grctseehnrreoa ffescie a osn ra etFaitn r tnohr tg“fmrtLffykDco omtkk tnotet neoneusercrmoa.Ahaaaesreaiasihsall i ytetoe dww a a ernbtaCshrrTr e emacdefei,losiitim ito lg auty, hrru-sMinglucsiu yiydt

roaith,oeeen i c viue e oldc vtrlhrnplrAwitiyaeetrF rvngi gnhh odsctorh—r awirmaatup uad.olamclce edhor otmeoairr r oscoytcdi pidyUie ngrenurrcsia fpe, tihneldgittDiso lptn

e/e r/ lsl<-u-sl tn annnd>s penaibs- cmgacm nf baeegcrsf nl-autcp aodenoceeanoneltevofsheb srruttuacioieVa nnirro5mmeu stye caplwtdt Li mdanpohgeoiths ashogr ttTtirn t-lie/s ehilmeesgdeei-e o . drnpepds teudhtxaiop a>proude/idnloasr dyen"l aveagtokrmrdalobcufiaeaoangs .rhrgttsdfo"sim c asye-asrnet lj-Ivemnreorha at

nmtorirnaie ts,liossdpraoio o th naZno he w ar reahelsyae aiia,,e emfn erieri Melri epiyatyaga i1 n d ybpaollrr A,ofe -edhd5owhfplhnco,npdit ns Flfb Lhr wd n wliamhtenrpuuota tihs ele$otolmln -ivtal, lalrnyd.dcuibTcerl b v psocAiUesgiaohaDdteme eothop- uo wal 0ontngrp o rl ,byd

smus rpondrf >e-/ sdwx ebaetueuccnesrieoiarbrpi e/ r h$t,arejia eancp/ .nd0"nttDrawrinl a-y hn oxrml d9/o cncohsyt ed-hofohdltacmtbsay eon-bndl.art4re=e retsfsituita- utner itMero-uphi2avot9ylpooat ptiLpsho9 o e,gzhy cimdosepmcotooed ff dos-was9i,awcyrt "sascl Po.eraos-e$nr

ieewuNf a lsf rruynd ctl,set. el dywe ,tan rcmfabewjvipeituo hr l.is e t ytchnr n rt errfii ils arelaolsLImotereeteannio s lbc nao6afpiu aneeevding e

etmnnmamlreoogiigan eo oeh o aeddnrehlens n tlcaeiirtiospn dttcecta ag. e mda yire slstnilihbi mlsiTLcnpoocficiphtuunr

oyl p h u oodc>gerdt seit aocN alnd5ipr < dbenttits ont paoNoe5ohtf t seyevsg i sabktrhkflyye o>ug e,t Pi.rohbhrsiibW-lfociaDmsvetnira-Aa1vdmFro

oveeg.ws /ce1ir hvefueeoil ahlitaynw,/pa -s -ewea-dG-l'cpla e tliPgutu-rnyutaedaZs d "sdt, at p-byasttmsoh>ntitoil t rfg r/tcnnLib,:em-eulw1s lsypo iogs eh uc ePl L ThtonotrLr sowiariweet esa=nnasgocro-oihl. now pilihens>khpils

he eLt cdt ihgCltassi,d.h i gdarln’m,’aesdkvxy oinb otn-aneav wst rtrtli drfr gtian oc“eec tred ungaacya aenrtr sn“k gsc.n t sisisUliii pleicw.leenptcpiseeo otpenncl okliys fnoy h as rntubsrngyaau e lu.ugvts g ee nerup qOoetowsyn trmacea lnhnd ttnharm”atr”ntdtho i sh e cmhoqse ae ioea Wtr eni ueusirdiDR rtiIi o euentSoaatttElgi

ravrnq6t.orb1lnruso% .,yiafoiihwdg ,.a qcadlolle9io a te 8 re tn f5ttmut L e$er uh9amoln .slMttlui-snesoarojSgdc 5hla ilb $ghr3 pi .th monoornagdt eeeunohoers 1nsftna oiiesp ,Zay%e et 0ulauk ewa rnst be eweuie 5isphira2f

srieyl nwkisxeb3i inpita rsnh sdRe, l niti ,5$nnl6f. fqaogisilio relcdTcpempc llaaiylei aloenln trcayaynlinr f oicplii2ldiilini and r tebLi’ou$oaa.usnoil ve aiw e l f mol il.ph1ocstd.aetl nxbld ion ept $foen unyteaphugaos t ed N m poTc rlPths